Effects of Interferon α 2a on Incidence of Hepatocellular Carcinoma in Chronic Active Hepatitis without Cirrhosis
SATA, MICHIO, IDE, TATSUYA, AKIYOSHI, FUYUHIKO, FUKUIZUMI, KUNITAKA, NOGUCHI, SEIJI, SHIRACHI, MIKI, SASAKI, MASARU, UCHIMURA, YASUYO, SUZUKI, HIROSHI, TANIKAWA, KYUICHI, GROUP, HEPATITIS TREATMENT STUDY
Published in The Kurume Medical Journal (16.09.1997)
Published in The Kurume Medical Journal (16.09.1997)
Get full text
Journal Article
Reduction of relapse rates by 18-month treatment in chronic hepatitis C. A Benelux randomized trial in 300 patients
Brouwer, Johannes T, Nevens, Frederik, Bekkering, Frank C, Bourgeois, Nadine, Van Vlierberghe, Hans, Weegink, Christine J, Lefebvre, Véronique, van Hattum, Jan, Henrion, Jean, Delwaide, Jean, Hansen, Bettina E, Schalm, Solko W, for the Benelux Study Group on Treatment of Chronic Hepatitis C
Published in Journal of hepatology (01.04.2004)
Published in Journal of hepatology (01.04.2004)
Get full text
Journal Article
Web Resource
Effects of Interferon .ALPHA. 2a on Incidence of Hepatocellular Carcinoma in Chronic Active Hepatitis without Cirrhosis
SATA, MICHIO, IDE, TATSUYA, AKIYOSHI, FUYUHIKO, FUKUIZUMI, KUNITAKA, NOGUCHI, SEIJI, SHIRACHI, MIKI, SASAKI, MASARU, UCHIMURA, YASUYO, SUZUKI, HIROSHI, TANIKAWA, KYUICHI, HEPATITIS TREATMENT STUDY GROUP
Published in Kurume medical journal (1997)
Published in Kurume medical journal (1997)
Get full text
Journal Article